Zydus Lifesciences Limited (NSE:ZYDUSLIFE)
India · Delayed Price · Currency is INR 906.65
-3.80 (-0.42%)
At close: Feb 17, 2026
Zydus Lifesciences Market Cap
Zydus Lifesciences has a market cap or net worth of 912.3 billion as of February 17, 2026. Its market cap has decreased by -2.74% in one year.
Market Cap
912.30B
Enterprise Value
965.86B
Revenue
260.89B
Ranking
n/a
PE Ratio
18.47
Stock Price
906.65
Market Cap Chart
Since May 15, 2002, Zydus Lifesciences's market cap has increased from 8.20B to 912.30B, an increase of 11,031.35%. That is a compound annual growth rate of 21.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 17, 2026 | 912.30B | -0.84% |
| Dec 31, 2025 | 920.05B | -5.90% |
| Dec 31, 2024 | 977.76B | 40.16% |
| Dec 29, 2023 | 697.61B | 64.11% |
| Dec 30, 2022 | 425.08B | -14.06% |
| Dec 31, 2021 | 494.62B | 1.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Divi's Laboratories | 1.63T |
| Cipla | 1.10T |
| Mankind Pharma | 860.00B |
| Aurobindo Pharma | 688.02B |
| Alkem Laboratories | 655.28B |
| Glenmark Pharmaceuticals | 573.01B |
| Laurus Labs | 546.58B |
| Ipca Laboratories | 379.31B |